SUBSCRIBE
SUBSCRIBE
News   Policy

GlaxoSmithKline Says Reports of Ireland Review Are “Completely Inaccurate”

June 10, 2010 | 
1 min read
in-Pharma Technologist -- GlaxoSmithKline (GSK) has described media reports of an overall review of operations in Ireland as “completely inaccurate”, telling in-PharmaTechnologist that the exercise only covers the plant in Cork.
Regulatory Europe
GlaxoSmithKline
MORE ON THIS TOPIC
Two businessmen negotiating with big speech bubbles
Rare diseases
Saol To Pitch Ultrarare Disease Drug as “Poster Child” for RDEP Program
December 9, 2025
 · 
2 min read
 · 
Heather McKenzie
FDA signage at its headquarters in Maryland
FDA
CAR-T Developers Will Need Randomized Trials as FDA Eyes Tighter Approval Requirements
December 9, 2025
 · 
2 min read
 · 
Tristan Manalac
Hands, tablet and doctor with body hologram, overlay and dna research for medical innovation on app. Medic man, nurse and mobile touchscreen for typing on anatomy study or 3d holographic ux in clinic
Policy
As FDA Deploys Agentic AI, Pharma Begins Testing the Next Frontier of Intelligent Automation
December 8, 2025
 · 
3 min read
 · 
Jennifer Smith-Parker
Balance, equilibrium and stability in a risky environment concepts. Spheres balancing on a seesaw. Abstract 3D render.
FDA
Rare Disease Leaders Call for Regulatory Consistency After Chaotic Year
December 8, 2025
 · 
8 min read
 · 
Heather McKenzie